PC
RVNC

PointState Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

PointState Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-438,200
Closed -$11.6M – 177
2017
Q2 		$11.6M Buy
438,200
+161,700
+58% +$3.61M 0.13% 83
2017
Q1 		$5.75M Buy
276,500
+101,500
+58% +$2.08M 0.06% 110
2016
Q4 		$3.62M Sell
175,000
-150,000
-46% -$2.51M 0.05% 101
2016
Q3 		$5.27M Buy
325,000
+75,000
+30% +$1.09M 0.05% 103
2016
Q2 		$3.4M Buy
+250,000
New +$4.42M 0.07% 76

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return